Effect of Serum Netrin-1 Levels on Diagnosis and Prognosis in Patients Admitted to the Emergency Service for Acute Coronary Syndrome.
acute coronary syndrome
netrin-1
reperfusion
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
20 Apr 2020
20 Apr 2020
Historique:
entrez:
27
5
2020
pubmed:
27
5
2020
medline:
27
5
2020
Statut:
epublish
Résumé
Background Netrin-1 is a recently discovered diagnostic biomarker that indicates atherosclerosis, angiogenesis, and ischemia-reperfusion damage. There are no human studies about Netrin-1 in acute coronary syndrome (ACS). The purpose of the present study was to investigate Netrin-1 levels in the early diagnosis and successful reperfusion of ACS. Method The study was conducted with 188 patients diagnosed with ACS and 50 healthy subjects at the emergency unit in a prospective design. Blood samples were collected from the patient group at initial admission and after angiography. The control group consisted of healthy adult subjects without any disease. Netrin-1 levels were studied in both groups. Results The Netrin-1 levels of the patient group at the time of admission were found to be higher than of the control group (p<0.001). In the patient group, netrin-1 levels measured at initial admission (1.53±0.19) and after angiography (1.49±0.19) were determined to be statistically significant (p:0.049). In the patient group, where the Thrombolysis in Myocardial Infarction (TIMI) 3 flow was established after angiography, netrin-1 levels were detected to be low (p:0.039). Netrin-1 levels obtained at the time of admission were determined to be significantly different in the Global Registry of Acute Coronary Events (GRACE) moderate and high-risk groups in comparison to the low-risk group (p:0.017). Conclusion Netrin-1 was shown to increase in the early diagnosis of ACS and to decrease in patients for whom reperfusion was established after angiography. Therefore, Netrin-1 can be an important biomarker as an indicator of diagnosis and successful reperfusion in ACS.
Identifiants
pubmed: 32455061
doi: 10.7759/cureus.7741
pmc: PMC7241224
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e7741Informations de copyright
Copyright © 2020, Mutlu et al.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Stroke. 2019 Apr;50(4):845-852
pubmed: 30852966
Circulation. 2000 Oct 24;102(17):2031-7
pubmed: 11044416
J Int Med Res. 2018 Jul;46(7):2670-2678
pubmed: 29761721
Eur Heart J. 2014 Mar;35(9):552-6
pubmed: 24357507
Arch Intern Med. 2003 Oct 27;163(19):2345-53
pubmed: 14581255
Front Biosci (Landmark Ed). 2014 Jan 01;19:566-70
pubmed: 24389204
Cell Cycle. 2010 Apr 15;9(8):1466-71
pubmed: 20372055
Eur Rev Med Pharmacol Sci. 2019 Jan;23(1):338-342
pubmed: 30657575
Cureus. 2020 Feb 28;12(2):e7135
pubmed: 32257680
Angiogenesis. 2008;11(1):23-9
pubmed: 18266062
Eur Heart J. 2010 Sep;31(18):2197-204
pubmed: 20685679
Ann Intern Med. 2018 Jun 19;168(12):855-865
pubmed: 29799975
Eur Heart J. 2012 Sep;33(18):2252-7
pubmed: 22723599
Scand J Clin Lab Invest. 2010 Jul;70(4):244-51
pubmed: 20367558
Stem Cells Dev. 2012 Jul 1;21(10):1769-78
pubmed: 21936706
Turk Kardiyol Dern Ars. 2011 Dec;39(8):654-60
pubmed: 22257803
Am J Respir Crit Care Med. 2010 Apr 15;181(8):815-24
pubmed: 20075388
J Mol Cell Cardiol. 2010 Jun;48(6):1060-70
pubmed: 20004665
PLoS One. 2009 Nov 23;4(11):e7947
pubmed: 19956773
BMC Health Serv Res. 2013 May 01;13:162
pubmed: 23635044
Coron Artery Dis. 2016 Jan;27(1):13-8
pubmed: 26267748
Eur Heart J. 2012 Oct;33(20):2551-67
pubmed: 22922414
Proc Natl Acad Sci U S A. 2006 Apr 25;103(17):6530-5
pubmed: 16611730